 MALVERN, Pa., March 07, 2022 GLOBE NEWSWIRE -- TELA Bio, Inc. TELA NASDAQ: TELA, a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patients own anatomy, today announced that it will release its fourth quarter and full year 2021 financial results on Monday, March 21, 2022. 